MATRIXOME, Inc.
PrivateLast Round
Seed
Jan 29, 2016
Est. Valuation
$6.54M
Total Funding Raised
$2.32M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MATRIXOME, Inc. is a biotechnology company that develops, produces, and distributes extracellular matrix (ECM) proteins, specifically recombinant laminin E8 fragments, for use in stem cell research and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MATRIXOME, Inc. Comparables
Compare MATRIXOME, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioLamina AB | 84% | |
| Sartorius Aktiengesellschaft | 72% | |
| Corning | 71% |
MATRIXOME, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 29, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 114% MoM, reaching 6K.
- Jun 19, 2026
Monthly visitors increased 48% MoM.
MATRIXOME, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MATRIXOME, Inc.'s valuation, stock price, and market status.
Is MATRIXOME, Inc. a public or private company?
MATRIXOME, Inc. is a private company.
What is the current stock price of MATRIXOME, Inc.?
MATRIXOME, Inc. is a private company, so its shares have no public market price. Caplight tracks MATRIXOME, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MATRIXOME, Inc. worth (valuation)?
MATRIXOME, Inc.'s valuation is estimated at $6.5M based on funding round data.
Can I buy MATRIXOME, Inc. stock?
MATRIXOME, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MATRIXOME, Inc.'s last funding round?
MATRIXOME, Inc.'s most recent funding round was Seed on January 29, 2016.
Who are the main investors in MATRIXOME, Inc.?
Investor information for MATRIXOME, Inc. is not publicly disclosed.
Will MATRIXOME, Inc. IPO soon?
No public IPO plans have been announced for MATRIXOME, Inc..
How can I track MATRIXOME, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in MATRIXOME, Inc.'s shares on secondary markets.